TABLE 1 | Highest ranked therapeutic/disease areas
From the following article:
Trends in disease focus of drug development
Johan P. E. Karlberg
Nature Reviews Drug Discovery 7, 639-640 (August 2008)
doi:10.1038/nrd2618
| Therapeutic/disease area | Year 1 | Year 2 | Total | Sites per protocols (n) | Growth* protocols (%) | Growth* sites (%) | |||
|---|---|---|---|---|---|---|---|---|---|
| Protocols (n) | Sites (n) | Protocols (n) | Sites (n) | Protocols (n) | Sites (n) | ||||
| Oncology | 405 | 13,375 | 419 | 10,520 | 824 | 23,895 | 29.0 | 103.5 | 78.7 |
| CNS | 337 | 10,141 | 333 | 5,753 | 670 | 15,894 | 23.7 | 98.8 | 53.2 |
| Cardiology | 346 | 11,166 | 257 | 6,888 | 603 | 18,054 | 29.9 | 74.3 | 61.7 |
| Infectious | 310 | 6,049 | 256 | 4,572 | 566 | 10,621 | 18.8 | 82.6 | 75.6 |
| Endocrinology | 272 | 11,120 | 276 | 5,677 | 548 | 16,797 | 30.7 | 101.5 | 51.1 |
| Respiratory | 144 | 4,637 | 160 | 4,237 | 304 | 8,874 | 29.2 | 111.1 | 91.4 |
| GI and hepatology | 120 | 5,173 | 108 | 3,016 | 228 | 8,189 | 35.9 | 90.0 | 58.3 |
| Kidney/urology | 94 | 2,560 | 114 | 2,231 | 208 | 4,791 | 23.0 | 121.3 | 87.1 |
| Ophthalmology | 85 | 526 | 92 | 865 | 177 | 1,391 | 7.9 | 108.2 | 164.4 |
| Rheumatology | 59 | 2,972 | 93 | 3,295 | 152 | 6,267 | 41.2 | 157.6 | 110.9 |
*Percentage increase: (number in Year 2)/(number in Year 1)  100. CNS, central nervous system; GI, gastrointestinal. | |||||||||
Download file
If the slide opens in your browser, select "File > Save As" to save it.
